OrphAI Therapeutics

Orphai Therapeutics is a biotechnology company dedicated to drug discovery through advanced computational biology and AI.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

About Us

OrphAI Therapeutics is a clinical-stage biopharmaceutical company developing novel treatments for rare diseases and cancer using AI-driven drug discovery. The company targets amyotrophic lateral sclerosis (ALS) and has received orphan drug designation in both the US and EU.

Latest Articles in AI